Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

AstraZeneca collaborates with Multiply Labs to scale cell therapy manufacturing using end-to-end GMP-ready robotic technology ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions - In the pharmaceutical industry, the ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after inking a long-term lease for manufacturing and office space in the Netherlands.

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and gene therapies.

The "Cell Therapy Human Raw Materials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has ...